Yosera Therapeutics Inc is categorized under Biological Products Manufacturers in San Francisco, CA and active since 2012.
Yosera Therapeutics Inc was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Biological Products Manufacturers business, which does work in the B2B market, and is classified as a Biological Products Manufacturers, under code number 325414 by the NAICS.
If you are seeking more information, feel free to contact Uri Lopatin at the company’s single location by writing to 1233 Howard St Apartment 716, San Francisco, California CA 94103 or by phoning (415) 935-1874. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Yosera Therapeutics Inc |
| Contact Person: | Uri Lopatin |
| Address: | 1233 Howard St Apartment 716, San Francisco, California 94103 |
| Phone Number: | (415) 935-1874 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biological Products Manufacturers |
| SIC Code: | 2836 |
| NAICS Code: | 325414 |
| Share This Business: |
Yosera Therapeutics Inc was started in 2012 to provide professional Biological Products Manufacturers under the SIC code 2836 and NAICS code 325414. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Uri Lopatin for inquiries that concern Yosera Therapeutics Inc by calling the company number (415) 935-1874, as your correspondence is most welcome. Additionally, the physical location of the single location of Yosera Therapeutics Inc can be found at the coordinates 37.775709,-122.412016 as well as the street address 1233 Howard St Apartment 716 in San Francisco, California 94103.
For its online presence, you may visit Yosera Therapeutics Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.